Literature DB >> 31556867

Insights from the revised complete genome sequences of Acinetobacter baumannii strains AB307-0294 and ACICU belonging to global clones 1 and 2.

Mohammad Hamidian1, Ryan R Wick2, Rebecca M Hartstein3, Louise M Judd2, Kathryn E Holt4,2, Ruth M Hall3.   

Abstract

The Acinetobacter baumannii global clone 1 isolate AB307-0294, recovered in the USA in 1994, and the global clone 2 (GC2) isolate ACICU, isolated in 2005 in Italy, were among the first A. baumannii isolates to be completely sequenced. AB307-0294 is susceptible to most antibiotics and has been used in many genetic studies, and ACICU belongs to a rare GC2 lineage. The complete genome sequences, originally determined using 454 pyrosequencing technology, which is known to generate sequencing errors, were re-determined using Illumina MiSeq and MinION (Oxford Nanopore Technologies) technologies and a hybrid assembly generated using Unicycler. Comparison of the resulting new high-quality genomes to the earlier 454-sequenced versions identified a large number of nucleotide differences affecting protein coding sequence (CDS) features, and allowed the sequences of the long and highly repetitive bap and blp1 genes to be properly resolved for the first time in ACICU. Comparisons of the annotations of the original and revised genomes revealed a large number of differences in the protein CDS features, underlining the impact of sequence errors on protein sequence predictions and core gene determination. On average, 400 predicted CDSs were longer or shorter in the revised genomes and about 200 CDS features were no longer present.

Entities:  

Keywords:  AB307-0294; ACICU; Acinetobacter baumannii; complete genome sequence; global clone 1; global clone 2

Year:  2019        PMID: 31556867      PMCID: PMC6861863          DOI: 10.1099/mgen.0.000298

Source DB:  PubMed          Journal:  Microb Genom        ISSN: 2057-5858


Data Summary

The corrected complete genome sequence of Acinetobacter baumannii AB307-0294 has been deposited in GenBank under accession number CP001172.2 (chromosome; url - https://www.ncbi.nlm.nih.gov/nuccore/CP001172.2). The corrected complete genome sequence of A. baumannii ACICU has been deposited in GenBank under accession numbers CP031380 (chromosome; url - https://www.ncbi.nlm.nih.gov/nuccore/CP031380), CP031381 (pACICU1; url - https://www.ncbi.nlm.nih.gov/nuccore/CP031381) and CP031382 (pACICU2; url - https://www.ncbi.nlm.nih.gov/nuccore/CP031382). The genomes of the first 10 Acinetobacter baumannii strains to be completely sequenced underpin a large amount of published genetic and genomic analysis. However, most of their genome sequences contain substantial numbers of errors as they were sequenced using 454 pyrosequencing, which is known to generate errors particularly in homopolymer regions; and employed manual PCR and capillary sequencing steps to bridge contig gaps and repetitive regions in order to finish the genomes. Assembly of the very large and internally repetitive genes for the biofilm-associated proteins Bap and Blp1 was a recurring problem. As these strains continue to be used for genetic studies and their genomes continue to be used as references in phylogenomics studies, including core gene determination, there is value in improving the quality of their genome sequences. To this end, we re-sequenced two such strains that belong to the two major globally distributed clones of , using a combination of highly accurate short-read and gap-spanning long-read technologies. Annotation of the revised genome sequences eliminated hundreds of incorrect coding sequence (CDS) feature annotations and corrected hundreds more. Given that these revisions affected hundreds of non-existent or incorrect CDS features currently cluttering GenBank protein databases, it can be envisaged that similar revision of other early bacterial genomes that were sequenced using error-prone technologies will affect thousands of CDSs currently listed in GenBank and other databases. These corrections will impact the quality of predicted protein sequence data stored in public databases. The revised genomes will also improve the accuracy of future genetic and comparative genomic analyses incorporating these clinically important strains.

Introduction

is a Gram-negative bacterium that has emerged as an important opportunistic pathogen, and is a research priority because of its high levels of resistance to antibiotics [1-3], desiccation and heavy metals [4, 5]. On a global scale, members of two clinically important clones, known as global clone 1 (GC1) and global clone 2 (GC2), have been responsible for the majority of outbreaks caused by multiply antibiotic-resistant strains [1–3, 6–8]. Whole-genome sequencing technologies have revolutionized the study of bacterial pathogens, allowing the entire gene repertoire of bacterial strains to be determined; hence, enabling the study of the relationships between outbreak strains with an unprecedented high resolution [9]. However, accuracy is important. The first 10 complete genomes of strains were reported between 2006 and 2012 (Table 1), and are still used as a baseline in many studies of this micro-organism [10-12]. Except for three strains (AYE, TCDC-AB0715 and TYTH-1), all of the early complete genomes were sequenced using 454 pyrosequencing technology and assembled using PCR. Pyrosequencing is known to generate frequent systematic sequencing errors, especially errors in the length of homopolymeric runs [13]; and these errors lead to erroneous protein coding sequence (CDS) prediction, often associated with fragmentation of genuine ORFs.
Table 1.

Properties of early completed genomes

Strain/plasmid

Country

Isolation date

GC

Original sequence

Revised

Revised sequence

Length

(bp)

GenBank no.

Sequencing technology

Reference

Length (bp)

GenBank no.

Sequencing technology

Reference

ATCC 17978

nk

1951

Chromosome

3 976 747

CP000521.1

454

[41]

Yes

3 857 743

CP012004.1

PacBio

[20]

pAB1

13 408

CP000522.1

454

No

Not present

na

nk

pAB2

11 302

CP000523.1

454

No

Not present

na

nk

pAB3

Not present

454

Yes

148 955

CP012005.1

PacBio

AYE

France

2001

1

Chromosome

3 936 291

CU459141.1

Illumina

[42]

No

p1ABAYE

5644

CU459137.1

Illumina

No

p2ABAYE

9661

CU459138.1

Illumina

No

p3ABAYE

94 413

CU459140.1

Illumina

No

p4ABAYE

2726

CU459139.1

Illumina

No

AB307-0294

USA

1994

1

Chromosome

3 760 981

CP001172.1

454

[26]

Yes

3 759 495

CP001172.2

MinION and Illumina

This study

AB0057

USA

2004

1

Chromosome

4 050 513

CP001182.1

454

[26]

Yes

4 055 148

CP001182.2

Illumina

[22]

pAB0057

8729

CP001183.1

454

Yes

8731

CP001183.2

Illumina

1656– 2

South Korea

2011*

2

Chromosome

3 940 614

CP001921.1

454

[43]

No

ABKp1

74 451

CP001922.1

454

No

ABKp2

8041

CP001923.1

454

No

ACICU

Italy

2005

2

Chromosome

3 904 116

CP000863.1

454

[27]

Yes

3 919 274

CP031380.1

MinION and Illumina

This study

pACICU1

28 279

CP000864.1

454

Yes

24 268

CP031381.1

MinION and Illumina

This study

pACICU2

64 366

CP000865.1

454

Yes

70 101

CP031382.1

MinION and Illumina

This study

TCDC-AB0715†

Taiwan

2007

2

Chromosome

4 130 792

CP002522.1

Illumina

[44]

Yes

4 138 388

CP002522.2

Illumina

p1ABTCDC0715

8731

CP002523.1

Illumina

No

P2ABTCDC0715

70 894

CP002524.1

Illumina

No

MDR-ZJ06

China

2006

2

Chromosome

3 991 133

CP001937.1

454

[45]

Yes

4 022 275

CP001937.2

PacBio

[24]

pMDR-ZJ06†

20 301

CP001938.1

454

Yes

Not present†

na

na

na

TYTH-1

Taiwan

2008

2

[46]

Chromosome

3 957 368

CP003856

Illumina

No

MDR-TJ

China

2012‡

2

Chromosome

3 964 912

CP003500.1

454

[47]

No

pABTJ1

77 528

CP003501.1

454

No

pABTJ2

110 967

CP004359.1

454

No

*Genome submission date; isolation date is not known.

†pMDR-ZJ06 is not present in the revised genome

‡Recovered between 2007 and 2012.

na, not applicable; nk, not known.

Properties of early completed genomes Strain/plasmid Country Isolation date GC Original sequence Revised Revised sequence Length (bp) GenBank no. Sequencing technology Reference Length (bp) GenBank no. Sequencing technology Reference ATCC 17978 nk 1951 Chromosome 3 976 747 CP000521.1 454 [41] Yes 3 857 743 CP012004.1 PacBio [20] pAB1 13 408 CP000522.1 No Not present na nk pAB2 11 302 CP000523.1 No Not present na nk pAB3 Not present Yes 148 955 CP012005.1 PacBio AYE France 2001 1 Chromosome 3 936 291 CU459141.1 Illumina [42] No p1ABAYE 5644 CU459137.1 Illumina No p2ABAYE 9661 CU459138.1 Illumina No p3ABAYE 94 413 CU459140.1 Illumina No p4ABAYE 2726 CU459139.1 Illumina No AB307-0294 USA 1994 1 Chromosome 3 760 981 CP001172.1 454 [26] Yes 3 759 495 CP001172.2 MinION and Illumina This study AB0057 USA 2004 1 Chromosome 4 050 513 CP001182.1 454 [26] Yes 4 055 148 CP001182.2 Illumina [22] pAB0057 8729 CP001183.1 454 Yes 8731 CP001183.2 Illumina 1656– 2 South Korea 2011* 2 Chromosome 3 940 614 CP001921.1 454 [43] No ABKp1 74 451 CP001922.1 454 No ABKp2 8041 CP001923.1 454 No ACICU Italy 2005 2 Chromosome 3 904 116 CP000863.1 454 [27] Yes 3 919 274 CP031380.1 MinION and Illumina This study pACICU1 28 279 CP000864.1 454 Yes 24 268 CP031381.1 MinION and Illumina This study pACICU2 64 366 CP000865.1 454 Yes 70 101 CP031382.1 MinION and Illumina This study TCDC-AB0715 Taiwan 2007 2 Chromosome 4 130 792 CP002522.1 Illumina [44] Yes 4 138 388 CP002522.2 Illumina p1ABTCDC0715 8731 CP002523.1 Illumina No P2ABTCDC0715 70 894 CP002524.1 Illumina No MDR-ZJ06 China 2006 2 Chromosome 3 991 133 CP001937.1 454 [45] Yes 4 022 275 CP001937.2 PacBio [24] pMDR-ZJ06† 20 301 CP001938.1 454 Yes Not present† na na na TYTH-1 Taiwan 2008 2 [46] Chromosome 3 957 368 CP003856 Illumina No MDR-TJ China 2012‡ 2 Chromosome 3 964 912 CP003500.1 454 [47] No pABTJ1 77 528 CP003501.1 454 No pABTJ2 110 967 CP004359.1 454 No *Genome submission date; isolation date is not known. †pMDR-ZJ06 is not present in the revised genome ‡Recovered between 2007 and 2012. na, not applicable; nk, not known. An additional problem in genomes determined using short-read sequence data followed by PCR gap closure arises from the many short internal repeats present in the very large bap gene (~8–25 kbp), which is hard to assemble accurately. This gene encodes the biofilm-associated protein Bap [14-17]. The bap gene was originally cloned from AB307-0294 (GC1), and found to be 25 863 bp with a complex configuration of internal repeats [15]. However, the size of the bap gene from a GC2 isolate was estimated at approximately 16 kbp [16]. In another study, the length of Bap proteins predicted from genomes available in GenBank appeared to be highly variable, mainly due to different numbers of copies of the various repeated segments and the ORF was often fragmented [17]. The blp1 gene, which is 9–10 kbp, encodes a further very large protein that also has internal repeats and is associated with biofilm formation [17]. Newer sequencing technologies such as PacBio (Pacific Biosciences) and MinION (Oxford Nanopore Technologies; ONT) can generate much longer sequencing reads [9], allowing gaps to be spanned. MinION-only assemblies are also prone to errors [18], but can be combined with high-accuracy Illumina short-read data to produce very-high-quality finished genome assemblies [19]. Long-read sequence data have enabled a re-assessment of early completed genomes, including several of the first 10 to be sequenced (Table 1). For example, in 2016, ATCC 17978 was re-sequenced using PacBio. This revealed the presence of a 148 kb conjugative plasmid, pAB3, fragments of which were erroneously merged into the chromosome in the original 454-based assembly [20]. This plasmid sequence brought together the parts of GIsul2, fragmented pieces of which had been randomly distributed in the chromosome in the original sequence [21]. In 2017, we revised the 454-based genome sequence of the GC1 strain AB0057 using Illumina HiSeq technology, and found that hundreds of single base additions or deletions changed >200 protein CDS features [22]. An additional copy of the oxa23 carbapenem-resistance gene, located in Tn2006, was also found in the revised sequence of the chromosome (GenBank accession no. CP001182.2) [22, 23]. A recent revision of the 454-based genome of the GC2 strain MDR-ZJ06 using PacBio sequencing led to the correction of hundreds of CDS features and allowed reassessment of the localization of important antimicrobial-resistance regions [24]. The position of transposon Tn2009, which carries the oxa23 gene, was revised; and a region originally reported as a plasmid, but that had been predicted to be a chromosomally located AbGRI3-type resistance island [25], was incorporated into the chromosome (CP001937.2) [24]. In the revised genome, the two arrays of gene cassettes carrying antibiotic-resistance genes in class 1 integrons are now in the correct resistance islands. These revisions exemplify the challenges encountered when relying solely on short-read data to assemble bacterial genomes, and highlight the extent and impact of pyrosequencing errors particularly on CDS predictions. Two further strains for which only early 454-based genome sequences are available are the largely antibiotic-susceptible isolate AB307-0294, recovered from the blood of a patient hospitalized in Buffalo, NY, USA, in 1994 [26], and the extensively antibiotic-resistant isolate ACICU recovered in 2005 from the cerebrospinal fluid of a patient in San Giovanni Addolorata Hospital in Rome, Italy (GenBank accession no. CP000863) [27]. AB307-0294 was one of the first GC1 strains to be completely sequenced [26] and has been extensively used in genetic studies [28-32]. It belongs to CC1 (clonal complex 1) [sequence type 1 (ST1)] in the Institut Pasteur multilocus sequence typing (MLST) scheme and to ST231 in the Oxford MLST scheme, and carries the KL1 capsule genes and OCL1 at the outer core locus [33]. Compared to other GC1 strains characterized to date, AB307-0294 is relatively susceptible to antibiotics [26], exhibiting resistance only to chloramphenicol (intrinsic) and nalidixic acid (acquired). It contains no plasmids. ACICU was the first GC2 isolate to be sequenced [27]. It belongs to ST2 in the Institut Pasteur MLST scheme, ST437 in the Oxford MLST scheme, and carries the KL2 capsule genes and OCL1 at the outer core locus [33]. ACICU is carbapenem resistant and also resistant to multiple antibiotics, including third-generation cephalosporins, sulfonamides, tetracycline, amikacin, kanamycin, netilmicin and ciprofloxacin [27]. It contains two plasmids [27]. However, we previously showed that the largest plasmid, pACICU-2, which was reported to include no resistance genes, is larger and contains the amikacin-resistance gene aphA6 in transposon TnaphA6. The central segment of TnaphA6, including the aphA6 gene and one of the ISAba125 copies as well as a 4.7 kb backbone segment, were missing in the original 454-based whole-genome sequence [34]. Here, we report revised complete genome sequences for strains AB307-0294 (GC1) and ACICU (GC2), generated using MiSeq (Illumina) and MinION (ONT) sequence data. The new genome sequences correct hundreds of protein CDS features generated by the presence of single nucleotide differences (S NDs) and small insertion/deletions of mainly 1–3 bases in the earlier 454 genome sequences.

Methods

Whole-genome sequencing, assembly and annotation

Whole-cell DNA was isolated and purified using a protocol described elsewhere [1, 35]. Libraries were prepared from whole-cell DNA isolated from AB307-0294 and ACICU, and were sequenced using Illumina MiSeq and ONT MinION. Paired-end reads of 150 bp and MinION reads of up to 20 kb were used to assemble each genome using Unicycler software (v0.4.0) [19] with default parameters. Protein CDS, rRNA and tRNA genes were annotated using the automatic annotation program Prokka v1.13 [36]. Regions containing antibiotic-resistance genes and the polysaccharide biosynthesis loci, biofilm-associated proteins and genes used in the MLST schemes were annotated manually. To compare previous CDS (≥25 aa CDS features) annotations with our new results, we wrote a script (github.com/rrwick/Compare-annotations) to quantify the differences. This script classifies CDSs in the annotations as either exact matches, inexact matches, only present in the first annotation or only present in the second annotation. We also used the Ideel pipeline of Dr Mick Watson (github.com/mw55309/ideel) to assess the completeness of CDSs annotated in each genome, by comparing the length of each CDS to that of its longest blast hit in the UniProt database (as described in http://www.opiniomics.org/a-simple-test-for-uncorrected-insertions-and-deletions-indels-in-bacterial-genomes/).

Results and Discussion

Revised genome of ACICU

ACICU, the first GC2 strain to be completely sequenced, contains AbaR2 in the chromosomal comM gene [27]. As this AbaR resistance island type is more usually found in this location in GC1 strains [37] with an AbGRI1 type island in GC2 isolates [38], ACICU may represent a rare GC2 lineage. Here, the ACICU genome was re-sequenced using a combination of Illumina (MiSeq, 58× depth) and ONT (MinION, 253× depth) data. The new contiguous ACICU chromosomal sequence comprised 3 919 274 bp (GenBank accession no. CP001172.2), compared to 3 904 116 bp in the original submission (GenBank accession no. CP000863), making the revised chromosome 15 158 bp longer (Table 1). Most of the additional length in the revised chromosome was found to be due to a 11.2 kbp longer bap gene (Table 2), which is just over 11 kbp and in nine smaller ORFs in the original sequence (locus_ids ACICU_02938 to ACICU_2946), as noted previously [17]. In the revised genome sequence, the bap gene is 22.2 kbp (locus_id DMO12_08904), mainly due to a large number of short strings of repeated sequences missing previously. Hence, some of the variation in the length of bap reported elsewhere [17] may be due to sequencing and assembly issues rather than genuine length variation in the population. The blp1 gene in the original sequence (locus_id ACICU_02910) is 9510 bp and 9813 bp (locus_id DMO12_08811) in the revised genome (Table 2).
Table 2.

Comparison of bap and blp1 genes in early complete genomes and their revisions

Genome

Revision

technology

bap

blp1

Size (bp)

Locus ID

Size (bp)

Locus ID

ATCC 17978

Original

6306

A1S_2696

–*

Revised

PacBio

6225

ACX60_04030

AB307-0294

Original

22 920

ABBFA_000776

10 071

ABBFA_000810

Revised

Nanopore

25863

ABBFA_00771

10 089

ABBFA_00802

ACICU

Original

6420

ACICU_02938-46

9510

ACICU_02910

Revised

Nanopore

22 212

DMO12_08904

9813

DM012_08811

MDR-ZJ06

Original

2115

ABZJ_03124

9135

ABZJ_03096

Revised

PacBio

7947

ABZJ_03955

9813

ABZJ_03096

*ATCC 17978 does not contain the blp1 gene.

Comparison of bap and blp1 genes in early complete genomes and their revisions Genome Revision technology bap blp1 Size (bp) Locus ID Size (bp) Locus ID ATCC 17978 6306 A1S_2696 –* Revised PacBio 6225 ACX60_04030 AB307-0294 Original 22 920 ABBFA_000776 10 071 ABBFA_000810 Revised Nanopore 25863 ABBFA_00771 10 089 ABBFA_00802 ACICU Original 6420 ACICU_02938-46 9510 ACICU_02910 Revised Nanopore 22 212 DMO12_08904 9813 DM012_08811 MDR-ZJ06 Original 2115 ABZJ_03124 9135 ABZJ_03096 Revised PacBio 7947 ABZJ_03955 9813 ABZJ_03096 *ATCC 17978 does not contain the blp1 gene. The revised chromosome of ACICU differs from the original at 281 positions, including 40 SNDs and 241 insertions or deletions of 1–3 bases (mostly in homopolymeric runs of As or Ts). The original annotation included 3677 protein-encoding features (CDS features are ≥25 aa), whereas the revised genome annotation contains 3605 CDS features. Comparison of the CDS features indicated that only 3129 CDSs are identical between the two versions. The differences are mostly due to the correction of ORFs that were interrupted or fused due to errors in the 454 sequence, and include 80 CDSs unique to the revised version and 142 CDS features in the original sequence that could not be found in the corrected chromosome. A further 396 CDSs that are present in both versions are altered: of these, 8 have the same length, 285 are longer in the revised chromosome and 103 are shorter. Overall, 98.8 % of all genes (n=3568) in the new assembly are within 5 % of the maximum length of homologous proteins in UniProt (i.e. the expected length), calculated using the Ideel pipeline (see Methods). In the old assembly, only 95.8 % (n=3494) of all genes were within 5 % of this expected length. The distribution of length ratios is shown in Fig. 1(a), highlighting a substantial population of CDSs annotated in the old assembly that have lengths well below those of homologous proteins in UniProt.
Fig. 1.

Histograms of CDS lengths relative to the length of the top hit in UniProt, in the original versus revised genomes. (a) ACICU GenBank accession no. CP000863.1 (original) and CP031380 (revised), (b) AB307-0294 GenBank accession no. CP001172.1 (original) and CP001172.2 (revised), and (c) ATCC 17978 GenBank accession no. CP000521.1 (original) and CP012004.1 (revised). The x-axis shows the ratio of CDS length to the length of the closest hit in the UniProt TrEMBL database. The y-axis shows gene frequency and is truncated at 100 (the centre bar extends to ~3000 genes). A tight distribution around 1.0 indicates that the assembly’s CDSs match known proteins, supporting few indel errors in the assembly. A left-skewed distribution is characteristic of an assembly with indel errors that lead to premature stop codons.

Histograms of CDS lengths relative to the length of the top hit in UniProt, in the original versus revised genomes. (a) ACICU GenBank accession no. CP000863.1 (original) and CP031380 (revised), (b) AB307-0294 GenBank accession no. CP001172.1 (original) and CP001172.2 (revised), and (c) ATCC 17978 GenBank accession no. CP000521.1 (original) and CP012004.1 (revised). The x-axis shows the ratio of CDS length to the length of the closest hit in the UniProt TrEMBL database. The y-axis shows gene frequency and is truncated at 100 (the centre bar extends to ~3000 genes). A tight distribution around 1.0 indicates that the assembly’s CDSs match known proteins, supporting few indel errors in the assembly. A left-skewed distribution is characteristic of an assembly with indel errors that lead to premature stop codons. ACICU carries two plasmids (Table 1), pACICU1 and pACICU2 [27], which encode the RepAci1 and RepAci6 replication initiation proteins [39]. The original pACICU1 sequence (GenBank accession no. CP000864) is 28 279 bp long and contains two copies of the carbapenem-resistance gene oxa58, while the revised pACICU1 (GenBank accession no. CP031381) is 24 268 bp long and includes only a single oxa58 copy. It lacks the region between the two IS26 and one copy of IS26 in the original sequence. The IS26-mediated duplication may have been generated during growth in selective media. The original and revised pACICU1 sequences also differed by three SNDs, six single bp insertions, and one single bp and two 2 bp deletions. We previously used a PCR mapping strategy [34] to show that the aphA6 gene and an additional ISAba125, as well as a 4.7 kb long backbone segment, located between two copies of a ~420 bp repeated segment, are missing from the original sequence of pACICU2, the larger plasmid of ACICU [34]. Here, the long-read sequences generated for pACICU2 (GenBank accession no. CP031382) confirmed this. The revised plasmid sequence differs by six SNDs from pAb-G7-2 (GenBank accession no. KF669606.1), a conjugative plasmid from a GC1 isolated in Australia in 2003 reported previously [40].

Revised genome of AB307-0294

The AB307-0294 genome was also sequenced using a combination of Illumina (MiSeq, 63× depth) and ONT (MinION, 120× depth) technologies. The hybrid assembly resulted in a single 3 759 495 bp chromosome (GenBank accession no. CP001172.2) compared with 3 760 981 bp in the original genome (GenBank accession no. CP001172.1), making the revised genome 1486 bp shorter (Table 1). As with AB0057, the majority of differences were found to be additions or deletions of 1–3 bases, usually in ‘A’ or ‘T’ in homopolymeric runs of these nucleotides. The original annotation included 3427 CDSs, while the revised annotation contains 3458 (≥25 aa), of which 2937 CDSs are identical in the two versions. Corrections of insertion/deletion errors changed 354 ORFs leading to merging and splitting of CDS regions. Amongst these 354 CDS features, 286 CDSs in the revised genome are longer and 65 are shorter than the corresponding CDSs in the original annotation, and 3 have the same length but differ internally. The revised genome also includes 136 novel CDS features, compared to the original sequence, while there are also 167 CDSs in the old sequence that no longer exist in the revised genome, again indicating the high impact of the errors caused by the use of 454 pyrosequencing technology. Overall, 98.9 % of all genes (n=3387) in the new assembly are within 5 % of the expected length, calculated using the Ideel pipeline, versus just 96.4 % (n=3336) in the old assembly (Fig. 1b). The bap gene was 25 863 bp (locus_id ABBFA_00771), the same length as reported originally [15] but 1067 bp shorter than the 26 930 bp bap gene in the original genome sequence where it is split into two ORFs (locus_id ABBFA_000776 and locus_id ABBFA_000777). The revised genome was found to contain a 10 089 bp blp1 gene (ABBFA_00802), only 18 bp longer than that in the original sequence (Table 2). Interestingly, both the original and revised genomes appear to be devoid of any insertion sequences.

Revised genomes affect many predicted protein sequences

To date, six early genome sequences, including AB307-0294 and ACICU reported here, have been corrected, and in each case the revised genome has resulted in the correction of ~600 CDS features on average [20, 22]. In each comparison of revised and original genome sequences, 100–150 new CDS features appeared, 150–200 CDSs disappeared and 150–200 CDSs changed. As the extent of errors had not been reported previously [20], we also compared the original (GenBank accession no. CP000521.1) and revised (GenBank accession no. CP012004.1) genomes of ATCC 17978. This revealed that the revised sequence has extensively re-ordered parts of the chromosome, correcting a large number of inversions, insertion/deletions and other misassemblies. A striking difference between the two genomes is the inclusion in the original chromosome assembly of several large segments that in fact make up a 148 kb plasmid (pAB3) carrying the sul2 sulfonamide-resistance gene (GenBank accession no. CP012005). The misassembly issues precluded a simple alignment of the two chromosome sequences, but alignment of 14 separate chromosomal segments totalling 3 843 892 bp, revealed 334 SNPs as well as 635 deletions and 754 insertions of 1–3 bases, mainly As or Ts in runs of As or Ts. Overall, 3503 genes (98.2 % of all genes) in the new assembly are within 5 % of the expected length, calculated using the Ideel pipeline, versus 3381 (86.4 %) in the old assembly (see Fig. 1c). Hence, the original assembly was substantially flawed and should not be used in future. However, although the original study reported that ATCC 17978 contains two cryptic plasmids of 13 kb, pAB1 (GenBank accession no. CP000522.1) and 11 kb, pAB2 (GenBank accession no. CP000523.1) [41], the revised genome does not include either of these plasmids. This may be due to an assembly parameter setting to filter out the small contigs, which would remove pAB1 and pAB2 from the final assembly. Granted the large effects observed on the length of bap and blp in ACICU using long-read data, their sizes in original and revised genomes in the remainder of the first set of 10 sequenced A. baumannii (Table 1) were compared and significant differences were observed only where long-read data were used in the revision. In the GC2 strain MDR-ZJ06 (GenBank accession no. CP001937), blp1 (locus tag ABZJ_03096) is 9812 bp in the revised genome (CP001937.2) versus 9134 bp in the original sequence (locus tag ABZJ_03096; Table 2). Further, bap, which is 7946 bp in the revised genome (locus_id ABZJ_03955), was split into three ORFs, ranging in size from 2 to 2.5 kb, in the original sequence. In ATCC 17978, the blp1 gene is not present in either the original or the revised genome. However, the bap gene, which was split into two ORFs (locus_id A1S_2696, 6306 bp; and A1S_2724, 1161 bp) and separated by 41 kbp in the original sequence is now in a single ORF (locus_id ACX60_04030; 6225 bp) in the revised genome and 842 bp shorter compared to the original genome (Table 2).

Conclusions

The revised genome sequences of AB307-0294 and ACICU will underpin more accurate studies of the genetics and genomic evolution of related strains belonging to GC1 and GC2. This work highlights the need to review and revise early bacterial genomes sequenced using short-read data and assembled with (or sometimes without) PCR to join contigs. Special attention needs to focus on the genomes determined using the 454 pyrosequencing technology in order to correct predicted protein sequences. Long-read data, such as those generated by PacBio and ONT (MinION) technologies, allow for complete genome assembly without manual intervention. While assembling long-read data alone can result in sequence errors and failure to detect small plasmids, hybrid assembly (using both short and long reads) can produce assemblies that are both complete and accurate. However, repetitive sequences in the genome, such as the genes encoding Bap and Blp1, are difficult to perfect even with hybrid assembly, so variations in these regions should be interpreted with caution. Finally, as the original GenBank entries are replaced by revised genomes, there is a need to eliminate non-existent and incorrect predicted protein sequences in order to simplify the already complex task of protein sequence searches. It can be assumed that this problem is not only limited to genomes as many bacterial species so far have been sequenced using 454 pyrosequencing technology.

Data bibliography

1. Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H et al. NCBI GenBank accession no. CP012952, A. baumannii AB307-0294 (2008). 2. Carattoli A, Villa L, Fortini D, Cassone A. NCBI GenBank accession no. CP000863.1, A. baumannii ACICU, complete genome (2007). 3. Hamidian M, Wick R, Judd L, Russo TA, Holt KE et al. NCBI GenBank accession no. CP012952, A. baumannii AB307-0294 (2017). 4. Hartstein RM, Hamidian M, Nigro SJ, Wick R, Judd L et al. NCBI GenBank accession no. CP031380.1, A. baumannii isolate ACICU (2019). 5. Hua X. NCBI GenBank accession no. CP001937.2, A. baumannii MDR-ZJ06, complete genome (2018). 6. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN et al. NCBI GenBank accession no. CP000521.1, A. baumannii ATCC 17978, complete genome (2008). 7. Weber BS, Ly PM, Irwin JN, Pukatzki S, Feldman MF. NCBI GenBank accession no. CP012004.1, A. baumannii ATCC 17978-mff, complete genome (2013).
  47 in total

1.  Relocation of Tn2009 and characterization of an ABGRI3-2 from re-sequenced genome sequence of Acinetobacter baumannii MDR-ZJ06.

Authors:  Xiaoting Hua; Qingye Xu; Zhihui Zhou; Shujuan Ji; Yunsong Yu
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.790

2.  Genome sequence of Acinetobacter baumannii TYTH-1.

Authors:  Ming-Li Liou; Chih-Chin Liu; Chia-Wei Lu; Ming-Feng Hsieh; Kai-Chih Chang; Han-Yueh Kuo; Chi-Ching Lee; Chun-Tien Chang; Cheng-Yao Yang; Chuan Yi Tang
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

3.  Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China.

Authors:  Hua Zhou; Tongwu Zhang; Dongliang Yu; Borui Pi; Qing Yang; Jianying Zhou; Songnian Hu; Yunsong Yu
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

4.  Genome sequence of a dominant, multidrug-resistant Acinetobacter baumannii strain, TCDC-AB0715.

Authors:  Chun-Chen Chen; Yu-Chi Lin; Wang-Huei Sheng; Yee-Chun Chen; Shan-Chwen Chang; Ko-Chiang Hsia; Mei-Hui Liao; Shu-Ying Li
Journal:  J Bacteriol       Date:  2011-03-11       Impact factor: 3.490

5.  Tn6167, an antibiotic resistance island in an Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 isolate.

Authors:  Steven J Nigro; Ruth M Hall
Journal:  J Antimicrob Chemother       Date:  2012-02-20       Impact factor: 5.790

6.  New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis.

Authors:  Michael G Smith; Tara A Gianoulis; Stefan Pukatzki; John J Mekalanos; L Nicholas Ornston; Mark Gerstein; Michael Snyder
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

7.  Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions.

Authors:  Bart A Eijkelkamp; Karl A Hassan; Ian T Paulsen; Melissa H Brown
Journal:  BMC Genomics       Date:  2011-02-23       Impact factor: 3.969

8.  Systematic exploration of error sources in pyrosequencing flowgram data.

Authors:  Susanne Balzer; Ketil Malde; Inge Jonassen
Journal:  Bioinformatics       Date:  2011-07-01       Impact factor: 6.937

9.  A novel method of consensus pan-chromosome assembly and large-scale comparative analysis reveal the highly flexible pan-genome of Acinetobacter baumannii.

Authors:  Agnes P Chan; Granger Sutton; Jessica DePew; Radha Krishnakumar; Yongwook Choi; Xiao-Zhe Huang; Erin Beck; Derek M Harkins; Maria Kim; Emil P Lesho; Mikeljon P Nikolich; Derrick E Fouts
Journal:  Genome Biol       Date:  2015-07-21       Impact factor: 13.583

10.  Comparative analysis of Acinetobacters: three genomes for three lifestyles.

Authors:  David Vallenet; Patrice Nordmann; Valérie Barbe; Laurent Poirel; Sophie Mangenot; Elodie Bataille; Carole Dossat; Shahinaz Gas; Annett Kreimeyer; Patricia Lenoble; Sophie Oztas; Julie Poulain; Béatrice Segurens; Catherine Robert; Chantal Abergel; Jean-Michel Claverie; Didier Raoult; Claudine Médigue; Jean Weissenbach; Stéphane Cruveiller
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

View more
  3 in total

1.  Structure of the Acinetobacter baumannii PmrA receiver domain and insights into clinical mutants affecting DNA binding and promoting colistin resistance.

Authors:  Samantha Palethorpe; Morgan E Milton; Everett C Pesci; John Cavanagh
Journal:  J Biochem       Date:  2022-01-07       Impact factor: 3.241

2.  Systematic Identification and Analysis of Acinetobacter baumannii Type VI Secretion System Effector and Immunity Components.

Authors:  Jessica M Lewis; Deanna Deveson Lucas; Marina Harper; John D Boyce
Journal:  Front Microbiol       Date:  2019-10-30       Impact factor: 5.640

Review 3.  Recent Advances in Genetic Tools for Acinetobacter baumannii.

Authors:  Ellen M E Sykes; Soumya Deo; Ayush Kumar
Journal:  Front Genet       Date:  2020-12-22       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.